Syndax Pharmaceuticals Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 533 | 0.0% | 25,384 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 391 | 0.0% | 25,384 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 238 | 0.0% | 25,384 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 312 | 0.0% | 25,384 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 336 | 0.0% | 25,384 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 489 | 0.0% | 25,384 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 926 | 0.0% | 45,098 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 1,132 | 0.0% | 47,575 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 626 | 0.0% | 28,983 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 448 | 0.0% | 30,825 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 623 | 0.0% | 29,745 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 627 | 0.0% | 29,685 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 951 | 0.0% | 37,374 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 898 | 0.0% | 37,362 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 676 | 0.0% | 35,148 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 563 | 0.0% | 32,394 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 709 | 0.0% | 32,371 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 620 | 0.0% | 32,465 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 665 | 0.0% | 38,751 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 552 | 0.0% | 24,700 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 549 | 0.0% | 24,700 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 365 | 0.0% | 24,700 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 366 | 0.0% | 24,700 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 199 | 0.0% | 18,100 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 159 | 0.0% | 18,100 | 12/31/2019 |